Literature DB >> 1552826

Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney.

J Gardes1, J M Poux, M F Gonzalez, F Alhenc-Gelas, J Menard.   

Abstract

A possible role of the endothelial L-arginine/NO pathway in the control of renal hemodynamics, renin release and kallikrein secretion was studied in an isolated rat kidney model perfused in a closed-circuit. NG-nitro-L-arginine methyl ester (L-NAME, 1-50 microM), an inhibitor of nitric oxide biosynthesis, caused a dose-dependent increase in perfusion pressure (PP) and a dose-dependent decrease in renal perfusate flow. Renin release was inhibited independently of a rise in PP. L-NAME did not change the urinary kallikrein secretion. These results confirm the intervention of the L-arginine/NO pathway in the vasodilation of this isolated perfused kidney model and demonstrate the inhibitory effect of L-NAME on renin release. They suggest that nitric oxide synthesis plays a role in stimulating renin release and is not involved in the regulation of urinary kallikrein secretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552826     DOI: 10.1016/0024-3205(92)90092-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney.

Authors:  H Scholz; A Kurtz
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Role of calcium ions in the pressure control of renin secretion from the kidneys.

Authors:  H Scholz; M Hamann; K H Götz; A Kurtz
Journal:  Pflugers Arch       Date:  1994-09       Impact factor: 3.657

3.  Coordinate changes of renin and brain-type nitric-oxide-synthase (b-NOS) mRNA levels in rat kidneys.

Authors:  K Schricker; B Pötzl; M Hamann; A Kurtz
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

4.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  Blockade of nitric oxide formation inhibits the stimulation of the renin system by a low salt intake.

Authors:  K Schricker; A Kurtz
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

6.  Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.

Authors:  K Schricker; I Hegyi; M Hamann; B Kaissling; A Kurtz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Eicosanoid-dependence of responses of pre- but not postglomerular vessels to noradrenaline in rat isolated kidneys.

Authors:  B L Zhang; J Sassard
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

8.  Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.

Authors:  J F Arnal; L Warin; J B Michel
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

9.  Role of cGMP-kinase II in the control of renin secretion and renin expression.

Authors:  C Wagner; A Pfeifer; P Ruth; F Hofmann; A Kurtz
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Endothelium derived relaxing factor is involved in the pressure control of renin gene expression in the kidney.

Authors:  K Schricker; R Della Bruna; M Hamann; A Kurtz
Journal:  Pflugers Arch       Date:  1994-10       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.